Frequently bought together:
Description
Mevalonic acid lithium salt | HY-113071A
Mevalonic acid lithium salt, a precursor in the mevalonate pathway, is essential for cell growth and proliferation.
IC50 & Target:
Human Endogenous Metabolite
Formule:
C6H11LiO4
SMILES:
O=C(O[Li])CC(C)(O)CCO
Stockage:
4°C, sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Related Products
Danoprevir | HY-10238
Gentaur
Danoprevir | HY-10238
Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases...
Sunitinib | HY-10255A
Gentaur
Sunitinib | HY-10255A
Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive...
Panobinostat | HY-10224
Gentaur
Panobinostat | HY-10224
Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities. Panobinostat induces HIV-1 virus production...
Adezmapimod | HY-10256
Gentaur
Adezmapimod | HY-10256
Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38β2, respectively. Adezmapimod inhibits...
Bortezomib | HY-10227
Gentaur
Bortezomib | HY-10227
Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts...